Investments
67Portfolio Exits
10Funds
4Partners & Customers
1About Lightstone Ventures
Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space. Lightstone invests in early stage therapeutics, with later stage investments pursued selectively.
Lightstone Ventures Headquarter Location
2884 Sand Hill Road Suite 121
Menlo Park, California, 94025,
United States
650-388-3676
Expert Collections containing Lightstone Ventures
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Lightstone Ventures in 1 Expert Collection, including Vitamin & Supplement Startups.
Vitamin & Supplement Startups
237 items
Research containing Lightstone Ventures
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Lightstone Ventures in 1 CB Insights research brief, most recently on Sep 25, 2019.
Latest Lightstone Ventures News
Feb 2, 2022
EIT Health-supported start-up, ProVerum, has raised USD 30 million in their Series A funding round with investments from Gilde Healthcare, Lightstone Ventures and Atlantic Bridge. Founded in Ireland, ProVerum has developed ProVee, a novel treatment solution for patients with symptomatic benign prostatic hyperplasia (BPH). The funding will help them to bring their innovative device to market in Europe and the US.
Lightstone Ventures Investments
67 Investments
Lightstone Ventures has made 67 investments. Their latest investment was in Reprieve Cardiovascular as part of their Unattributed VC on June 6, 2022.
Lightstone Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/8/2022 | Unattributed VC | Reprieve Cardiovascular | $15M | No | 1 | |
4/12/2022 | Series D | Contego Medical | $15.07M | No | 2 | |
11/16/2021 | Series D | Cala Health | $77M | No | 17 | |
10/12/2021 | Series A | |||||
8/25/2021 | Series C - IV |
Date | 6/8/2022 | 4/12/2022 | 11/16/2021 | 10/12/2021 | 8/25/2021 |
|---|---|---|---|---|---|
Round | Unattributed VC | Series D | Series D | Series A | Series C - IV |
Company | Reprieve Cardiovascular | Contego Medical | Cala Health | ||
Amount | $15M | $15.07M | $77M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 1 | 2 | 17 |
Lightstone Ventures Portfolio Exits
10 Portfolio Exits
Lightstone Ventures has 10 portfolio exits. Their latest portfolio exit was Vigil Neuroscience on January 07, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
1/7/2022 | IPO | Public | 7 | ||
6/18/2021 | IPO | Public | 1 | ||
2/8/2021 | Reverse Merger | 4 | |||
Date | 1/7/2022 | 6/18/2021 | 2/8/2021 | ||
|---|---|---|---|---|---|
Exit | IPO | IPO | Reverse Merger | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | |||
Sources | 7 | 1 | 4 |
Lightstone Ventures Fund History
4 Fund Histories
Lightstone Ventures has 4 funds, including Lightstone Ventures III.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
9/14/2021 | Lightstone Ventures III | $375M | 2 | ||
9/20/2017 | Lightstone Ventures II | ||||
1/26/2016 | Lightstone Singapore | ||||
5/1/2014 | Lightstone Ventures |
Closing Date | 9/14/2021 | 9/20/2017 | 1/26/2016 | 5/1/2014 |
|---|---|---|---|---|
Fund | Lightstone Ventures III | Lightstone Ventures II | Lightstone Singapore | Lightstone Ventures |
Fund Type | ||||
Status | ||||
Amount | $375M | |||
Sources | 2 |
Lightstone Ventures Partners & Customers
1 Partners and customers
Lightstone Ventures has 1 strategic partners and customers. Lightstone Ventures recently partnered with Ireland Strategic Investment Fund on July 7, 2020.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
7/1/2020 | Partner | Ireland | State-backed ALX Oncology lines up a $100m IPO The Ireland Strategic Investment Fund has a minority interest in the company through its partnership with Lightstone Ventures . | 1 |
Date | 7/1/2020 |
|---|---|
Type | Partner |
Business Partner | |
Country | Ireland |
News Snippet | State-backed ALX Oncology lines up a $100m IPO The Ireland Strategic Investment Fund has a minority interest in the company through its partnership with Lightstone Ventures . |
Sources | 1 |
Lightstone Ventures Team
5 Team Members
Lightstone Ventures has 5 team members, including current General Partner, Michael Carusi.
Name | Work History | Title | Status |
|---|---|---|---|
Michael Carusi | General Partner | Current | |
Ralph E Christoffersen | General Partner | Current | |
Jean George | General Partner | Current | |
Jason Lettmann | Promedior, Split Rock Partners, Accenture, and University of Iowa | General Partner | Current |
Adam Bruce | Advanced Technology Ventures | Chief Financial Officer | Former |
Name | Michael Carusi | Ralph E Christoffersen | Jean George | Jason Lettmann | Adam Bruce |
|---|---|---|---|---|---|
Work History | Promedior, Split Rock Partners, Accenture, and University of Iowa | Advanced Technology Ventures | |||
Title | General Partner | General Partner | General Partner | General Partner | Chief Financial Officer |
Status | Current | Current | Current | Current | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.